Search Results - "Ravenscroft, J."

Translating Patient-Oriented Eczema Measure (POEM) scores into clinical practice by suggesting severity strata derived using anchor-based methods by Charman, C.R., Venn, A.J., Ravenscroft, J.C., Williams, H.C.

“…Summary Background The Patient‐Oriented Eczema Measure (POEM) is a validated, patient‐derived assessment measure for monitoring atopic eczema severity,…”
Get full text

Interventions to reduce Staphylococcus aureus in the management of atopic eczema: an updated Cochrane review by Bath-Hextall, F.J., Birnie, A.J., Ravenscroft, J.C., Williams, H.C.

“…Summary Background  An association between the bacterium Staphylococcus aureus and atopic eczema has been recognized for many years. Although few would dispute…”
Get full text

British Association of Dermatologists guidelines for the management of people with vitiligo 2021 by Eleftheriadou, V., Atkar, R., Batchelor, J., McDonald, B., Novakovic, L., Patel, J.V., Ravenscroft, J., Rush, E., Shah, D., Shah, R., Shaw, L., Thompson, A.R., Hashme, M., Exton, L.S., Mohd Mustapa, M.F., Manounah, L.

“…Linked Comment: K. Ezzedine and A.G. Pandya. Br J Dermatol 2022; 186:3–4. Plain language summary available online…”
Get full text

What is the demand for out‐of‐hours dermatology? A UK‐based region‐wide survey of dermatology demand and provision during the evenings and at weekends by Roberts, E. J., Mann, J., Ravenscroft, J. C.

“…Summary Background Little is known about the demand for out‐of‐hours (OOH) dermatology in the UK, and this can make commissioning of acute services difficult…”
Get full text

The Eczema Priority Setting Partnership: a collaboration between patients, carers, clinicians and researchers to identify and prioritize important research questions for the treatment of eczema by Batchelor, J.M., Ridd, M.J., Clarke, T., Ahmed, A., Cox, M., Crowe, S., Howard, M., Lawton, S., McPhee, M., Rani, A., Ravenscroft, J.C., Roberts, A., Thomas, K.S.

“…Summary Background  Eczema is a common condition, yet there are uncertainties regarding many frequently used treatments. Knowing which of these uncertainties…”
Get full text

Which outcomes should we measure in vitiligo? Results of a systematic review and a survey among patients and clinicians on outcomes in vitiligo trials by Eleftheriadou, V., Thomas, K.S., Whitton, M.E., Batchelor, J.M., Ravenscroft, J.C.

“…Summary Background  Relevant and reliable outcomes play a crucial role in the correct interpretation and comparison of the results of clinical trials. There is…”
Get full text

Oral propranolol in the treatment of proliferating infantile haemangiomas: British Society for Paediatric Dermatology consensus guidelines by Solman, L., Glover, M., Beattie, P.E., Buckley, H., Clark, S., Gach, J.E., Giardini, A., Helbling, I., Hewitt, R.J., Laguda, B., Langan, S.M., Martinez, A.E., Murphy, R., Proudfoot, L., Ravenscroft, J., Shahidullah, H., Shaw, L., Syed, S.B., Wells, L., Flohr, C.

“…Summary Background Infantile haemangiomas (IH) are the most common vascular tumours of infancy. Despite their frequency and potential complications, there are…”
Get full text

Genotype–phenotype correlation in a large English cohort of patients with autosomal recessive ichthyosis by Simpson, J.K., Martinez‐Queipo, M., Onoufriadis, A., Tso, S., Glass, E., Liu, L., Higashino, T., Scott, W., Tierney, C., Simpson, M.A., Desomchoke, R., Youssefian, L., SaeIdian, A.H, Vahidnezhad, H., Bisquera, A., Ravenscroft, J., Moss, C., O'Toole, E.A., Burrows, N., Leech, S., Jones, E.A., Lim, D., Ilchyshyn, A., Goldstraw, N., Cork, M.J., Darne, S., Uitto, J., Martinez, A.E., Mellerio, J.E., McGrath, J.A.

“…Summary Background Recessive forms of congenital ichthyosis encompass a group of rare inherited disorders of keratinization leading to dry, scaly skin. So far,…”
Get full text

Propranolol in the treatment of infantile haemangiomas: lessons from the European Propranolol In the Treatment of Complicated Haemangiomas (PITCH) Taskforce survey by Wedgeworth, E., Glover, M., Irvine, A.D., Neri, I., Baselga, E., Clayton, T.H., Beattie, P.E., Bjerre, J.V., Burrows, N.P., Foelster-Holst, R., Hedelund, L., Hernandez-Martin, A., Audrain, H., Bhate, K., Brown, S.J., Baryschpolec, S., Darne, S., Durack, A., Dvorakova, V., Gach, J., Goldstraw, N., Goodyear, H., Grabczynska, S., Greenblatt, D., Halpern, J., Hearn, R.M.R., Hoey, S., Hughes, B., Jayaraj, R., Johansson, E.K., Lam, M., Leech, S., O'Regan, G.M., Morrison, D., Porter, W., Ramesh, R., Schill, T., Shaw, L., Taylor, A.E.M., Taylor, R., Thomson, J., Tiffin, P., Tsakok, M., Janmohamed, S.R., Laguda, B., McPherson, T., Oranje, A.P., Patrizi, A., Ravenscroft, J.C., Shahidullah, H., Solman, L., Svensson, A., Wahlgren, C.F., Hoeger, P.H., Flohr, C.

“…Summary Background Oral propranolol is widely prescribed as first‐line treatment for infantile haemangiomas (IHs). Anecdotally, prescribing practice differs…”
Get full text

Taipan snake venom time for antiphospholipid syndrome solves a 20‐year diagnostic challenge by Cunliffe, A., Dobson, J., Swallow, G., Ravenscroft, J., Tang, T. S.

“…Click here for the corresponding questions to this CME article…”
Get full text

Identifying the best predictive diagnostic criteria for psoriasis in children (< 18 years): a UK multicentre case–control diagnostic accuracy study (DIPSOC study) by Burden‐Teh, E., Murphy, R., Gran, S., Nijsten, T., Hughes, C., Abdul‐Wahab, A., Bewley, A., Burrows, N., Darne, S., Gach, J.E., Katugampola, R., Jury, C.S., Kuet, K., Llewellyn, J., McPherson, T., Ravenscroft, J.C., Taibjee, S., Wilkinson, C., Thomas, K.S.

“…Summary Background In children, psoriasis can be challenging to diagnose. Difficulties arise from differences in the clinical presentation compared with…”
Get full text

Randomized controlled trial of topical corticosteroid and home‐based narrowband ultraviolet B for active and limited vitiligo: results of the HI‐Light Vitiligo Trial by Thomas, K.S., Batchelor, J.M., Akram, P., Chalmers, J.R., Haines, R.H., Meakin, G.D., Duley, L., Ravenscroft, J.C., Rogers, A., Sach, T.H., Santer, M., Tan, W., White, J., Whitton, M.E., Williams, H.C., Cheung, S.T., Hamad, H., Wright, A., Ingram, J.R., Levell, N.J., Goulding, J.M.R., Makrygeorgou, A., Bewley, A., Ogboli, M., Stainforth, J., Ferguson, A., Laguda, B., Wahie, S., Ellis, R., Azad, J., Rajasekaran, A., Eleftheriadou, V., Montgomery, A.A.

“…Summary Background Evidence for the effectiveness of vitiligo treatments is limited. Objectives To determine the effectiveness of (i) handheld narrowband UVB…”
Get full text

Quality assurance and characterization of narrowband ultraviolet B devices for use at home: lessons from the HI‐Light Vitiligo Trial by Rogers, A., Akram, P., Batchelor, J.M., Crutchley, J., Grocki, M., Haines, R.H., Meakin, G., O’Dowd, K., Ravenscroft, J., Thomas, K.S.

Get full text

Recurrent chilblains in a child with neurological impairment by Mohandas, P., Bowker, R., Ravenscroft, J., Bleiker, T.

“…Click here for the corresponding questions to this CME article…”
Get full text

An economic evaluation of the randomized controlled trial of topical corticosteroid and home‐based narrowband ultraviolet B for active and limited vitiligo (the HI‐Light Vitiligo Trial) by Sach, T.H., Thomas, K.S., Batchelor, J.M., Perways, A., Chalmers, J.R., Haines, R.H., Meakin, G.D., Duley, L., Ravenscroft, J.C., Rogers, A., Santer, M., Tan, W., White, J., Whitton, M.E., Williams, H.C., Cheung, S.T., Hamad, H., Wright, A., Ingram, J.R., Levell, N., Goulding, J.M.R., Makrygeorgou, A., Bewley, A., Ogboli, M., Stainforth, J., Ferguson, A., Laguda, B., Wahie, S., Ellis, R., Azad, J., Rajasekaran, A., Eleftheriadou, V., Montgomery, A.A.

“…Summary Background Economic evidence for vitiligo treatments is absent. Objectives To determine the cost‐effectiveness of (i) handheld narrowband ultraviolet B…”
Get full text

Future research into the treatment of vitiligo: where should our priorities lie? Results of the vitiligo priority setting partnership by Eleftheriadou, V., Whitton, M.E., Gawkrodger, D.J., Batchelor, J., Corne, J., Lamb, B., Ersser, S., Ravenscroft, J., Thomas, K.S.

“…Summary Background  Vitiligo is the most frequent depigmentation disorder of the skin and is cosmetically and psychologically devastating. A recently updated…”
Get full text

A study of gene mutations and how they relate to the different types of ichthyosis by Simpson, J.K., Martinez‐Queipo, M., Onoufriadis, A., Tso, S., Glass, E., Liu, L., Higashino, T., Scott, W., Tierney, C., Simpson, M.A., Desomchoke, R., Youssefian, L., SaeIdian, A.H., Vahidnezhad, H., Bisquera, A., Ravenscroft, J., Moss, C., O'Toole, E.A., Burrows, N., Leech, S., Jones, E.A., Lim, D., Ilchyshyn, A., Goldstraw, N., Cork, M.J., Darne, S., Uitto, J., Martinez, A.E., Mellerio, J.E., McGrath, J.A.

“…Summary Ichthyosis is a disorder in which the skin is very thick and scaly. It is usually caused by a genetic mistake (mutation). “Autosomal recessive”…”
Get full text

Extension of Life-Span with Superoxide Dismutase/Catalase Mimetics by Melov, Simon, Ravenscroft, Joanne, Malik, Sarwatt, Gill, Matt S., Walker, David W., Clayton, Peter E., Wallace, Douglas C., Malfroy, Bernard, Doctrow, Susan R., Lithgow, Gordon J.

“…We tested the theory that reactive oxygen species cause aging. We augmented the natural antioxidant systems of Caenorhabditis elegans with small synthetic…”
Get full text

BSPD guidelines for treatment of IH with propranolol by Solman, L., Glover, M., Beattie, P.E., Buckley, H., Clark, S., Gach, J.E., Giardini, A., Helbling, I., Hewitt, R.J., Laguda, B., Langan, S.M., Martinez, A.E., Murphy, R., Proudfoot, L., Ravenscroft, J., Shahidullah, H., Shaw, L., Syed, S.B., Wells, L., Flohr, C.

“…Summary Infantile haemangiomas (IH) are common birthmarks in babies consisting of dilated blood vessels. They are also known as strawberry naevi. Most of them…”
Get full text

Interventions to reduce Staphylococcus aureus in the management of atopic eczema: an updated Cochrane review by Bath-Hextall, F.J., Birnie, A.J., Ravenscroft, J.C., Williams, H.C.

Get full text